Studies revealed that omentin-1 enhances insulin-stimulated glucose uptake in vitro in both omental and subcutaneous adipocytes and its serum levels are reduced in patients with T2DM and glucose intolerance [6, 10]. This evidence concerns the gene INS and type 2 diabetes mellitus.